Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10328822 | 0.92 | BACE1 (0.59) | BACE1BACE2 | |
| SCHEMBL17327471 | 0.91 | BACE1 (0.69) | BACE1BACE2 | |
| SCHEMBL17327345 | 0.90 | BACE1 (0.67) | BACE1BACE2 | |
| SCHEMBL17327443 | 0.89 | BACE1 (0.68) | BACE1BACE2 | |
| SCHEMBL17327347 | 0.89 | BACE1 (0.67) | BACE1BACE2 | |
| SCHEMBL17327343 | 0.89 | BACE1 (0.54) | BACE1BACE2 | |
| SCHEMBL17327354 | 0.87 | BACE1 (0.69) | BACE1BACE2 | |
| SCHEMBL10328844 | 0.86 | BACE1 (0.53) | BACE1BACE2 | |
| SCHEMBL10329286 | 0.86 | BACE1 (0.57) | BACE1BACE2 | |
| SCHEMBL10328973 | 0.84 | BACE1 (0.52) | BACE1BACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2931284-B1 | BACE INHIBITORS OF IMINOTHIADIAZINE DIOXIDES | MERCK SHARP & DOHME (US) | 2017-08-23 | — | — | EP | disclosed |
| US-9447085-B2 | Iminothiadiazine dioxides containing a thioamide, amidine, or amide oxime group as BACE inhibitors, compositions, and their use | MERCK SHARP & DOHME CORP. (US) | 2016-09-20 | — | — | US | disclosed |
| US-20150353516-A1 | IMINOTHIADIAZINE DIOXIDES CONTAINING A THIOAMIDE, AMIDINE, OR AMIDE OXIME GROUP AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE | MERCK SHARP & DOHME LLC | 2015-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150353516-A1 | IMINOTHIADIAZINE DIOXIDES CONTAINING A THIOAMIDE, AMIDINE, OR AMIDE OXIME GROUP AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE | BACE2, BACE1, APP | BACE1 2/4885BACE2 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.